DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 38 · September 2005 DOI: 10.1055/s-002-4370

Review

  • 187
  • Original Paper

  • 194
  • 201
  • 206
    Lambert, M.; Conus, P.; Schimmelmann, B. G.; Eide, P.; Ward, J.; Yuen, H.; Schacht, M.; Edwards, J.; Naber, D.; McGorry, P. D.:

    Comparison of Olanzapine and Risperidone in 367 First-Episode Patients with Non-Affective or Affective Psychosis: Results of an Open Retrospective Medical Record Study

  • 214
    Szulc, A.; Galinska, B.; Tarasow, E.; Dzienis, W.; Kubas, B.; Konarzewska, B.; Walecki, J.; Alathiaki, A. S.; Czernikiewicz, A.:

    The Effect of Risperidone on Metabolite Measures in the Frontal Lobe, Temporal Lobe, and Thalamus in Schizophrenic Patients. A Proton Magnetic Resonance Spectroscopy (1H MRS) Study

  • Letter

  • 220
    Khaldi, S.; Gourevitch, R.; Matmar, M.; Llory, A.; Olié, J.-P.; Chauvelot-Moachon, L.:

    Necrotizing Enterocolitis after Antipsychotic Treatment Involving Clozapine and Review of Severe Digestive Complications

  • 222
    Croissant, B.; Grosshans, M.; Klein, O.; Diehl, A.; Mann, K.:

    Scheme-Based Benzodiazepine Detoxification with Oxcarbazepine

  • 223
    Barnhill, J.; Susce, M. T.; Diaz, F. J.; de Leon, J.:

    Risperidone Half-Life in a Patient Taking Paroxetine

  • 225
  • 226